ReviewPolymers2026
Soft, Reactive, and Alive: A Dynamic Framework for Degradation and Functional Stability of Polymeric Biomaterials.
Review in Polymers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Polymeric biomaterials do not degrade in vivo through isolated chemical or mechanical events. Hydrolysis, oxidation, enzymatic cleavage, fatigue, wear, protein adsorption, and lipid uptake often interact across the material surface, bulk, and surrounding biological environment, producing time-dependent changes in both structure and function. Here, we propose a conceptual framework for organizing polymer degradation under biomedical conditions as a directional network of coupled mechanisms, emphasizing how established degradation pathways can influence one another and collectively contribute to time-dependent functional loss. The framework distinguishes degradation reactions from interfacial modulators and links molecular damage to functionality retention, defined according to application-specific endpoints such as mechanical strength, mass retention, dimensional stability, or interfacial performance. We introduce a qualitative interaction matrix to describe how individual mechanisms can amplify or modulate downstream pathways, and we use this matrix to identify recurrent degradation archetypes across major biomedical polymer classes, including polyesters, polyolefins, polyamides, polyurethanes, silicones, polyacrylates, polyvinyl polymers, polyimides, and natural polymers. This perspective emphasizes that material optimization strategies rarely eliminate degradation; instead, they shift the hierarchy of active pathways. By reframing biocompatibility as a dynamic, functionality-dependent property, the proposed framework provides a structured basis for comparing polymeric biomaterials, designing more realistic in vitro tests, and developing future data-driven models of long-term implant performance.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.